Mean change from baseline in meibomian gland expression scores at 1 to 4 weeks (higher is favored) · people with dry eye
It is very uncertain whether lipiFlow changes mean change from baseline in meibomian gland expression scores at 1… compared with basic warm compresses (very low certainty).
1 finding from 1 review
Mean change from baseline in meibum quality scores at 1 to 4 weeks (higher is favored) · people with dry eye
It is very uncertain whether lipiFlow changes mean change from baseline in meibum quality scores at 1 to 4 weeks… compared with basic warm compresses (very low certainty).
1 finding from 1 review
Proportion of participants with intervention‐related, vision‐threatening adverse events at 1 to 4 weeks · people with dry eye
1 finding from 1 review
Mean change from baseline in meibomian gland expression scores at 1 to 4 weeks (higher is favored) · people with dry eye
LipiFlow showed no clear difference in mean change from baseline in meibomian gland expression scores at 1… compared with thermostatic devices (low certainty).
1 finding from 1 review
Mean change from baseline in meibum quality scores at 1 to 4 weeks (higher is favored) · people with dry eye
LipiFlow showed no clear difference in mean change from baseline in meibum quality scores at 1 to 4 weeks… compared with thermostatic devices (low certainty).
1 finding from 1 review
Weight gain · promoting short‐term growth of preterm infants
2 findings from 1 review
Length gain, cm/week (high MCT vs low MCT) · promoting short‐term growth of preterm infants
1 finding from 1 review
Growth: head circumference (cm/week) · promoting short‐term growth of preterm infants
1 finding from 1 review
Skinfold thickness gain (mm/week) (high MCT vs low MCT) · promoting short‐term growth of preterm infants
1 finding from 1 review
Intervention not reported
Use of 1 or more red blood cell transfusions (low and high doses of EPO) · preterm infants with low birth weight
The intervention may leads to lower use of 1 or more red blood cell transfusions (low and high doses of… (low certainty).
1 finding from 1 review
Intervention not reported
Use of one or more red blood cell transfusions (low and high dose of EPO) during initial hospital stay · preterm infants with low birth weight
It is very uncertain whether the intervention changes use of one or more red blood cell transfusions (low and high dose of… (very low certainty).
1 finding from 1 review
Pain intensity VAS (0 to 100; 0 = no pain, 100 = worst pain) · Patients with acute low‐back pain
1 finding from 1 review
Disability RMDQ (0 to 24; lower = better) · Patients with acute low‐back pain
1 finding from 1 review
Proportion of participants experiencing global improvement % of dichotomized Likert scale · Patients with acute low‐back pain
NSAIDs may leads to higher proportion of participants experiencing global improvement Various… compared with placebo (low certainty).
1 finding from 1 review
Change in pain intensity from baseline on VAS (0 to 100) short‐term · Patients with acute low‐back pain
1 finding from 1 review
Disability ODI (0 to 50; lower = better) · Patients with acute low‐back pain
1 finding from 1 review
Improvement in lower limb perfusion: ABI · people with critical limb ischaemia
1 finding from 1 review
Improvement in lower limb perfusion: TcO₂ reading in mmHg · people with critical limb ischaemia
1 finding from 1 review
Improvement in lower limb perfusion: ABI · people with critical limb ischaemia
It is very uncertain whether IM injection changes improvement in lower limb perfusion: number of participants with… compared with IA injection (very low certainty).
1 finding from 1 review
Improvement in lower limb perfusion: number of participants with improved TcO₂ reading · people with critical limb ischaemia
It is very uncertain whether IM injection changes improvement in lower limb perfusion: number of participants with… compared with IA injection (very low certainty).
1 finding from 1 review